BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tata B, Mimouni NEH, Barbotin AL, Malone SA, Loyens A, Pigny P, Dewailly D, Catteau-Jonard S, Sundström-Poromaa I, Piltonen TT, Dal Bello F, Medana C, Prevot V, Clasadonte J, Giacobini P. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat Med 2018;24:834-46. [PMID: 29760445 DOI: 10.1038/s41591-018-0035-5] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 33.8] [Reference Citation Analysis]
Number Citing Articles
1 Smirnov VV, Beeraka NM, Butko DY, Nikolenko VN, Bondarev SA, Achkasov EE, Sinelnikov MY, Sinelnikov PRH. Updates on Molecular Targets and Epigenetic-Based Therapies for PCOS. Reprod Sci 2022. [PMID: 35764857 DOI: 10.1007/s43032-022-01013-x] [Reference Citation Analysis]
2 Monniaux D, Genêt C, Maillard V, Jarrier P, Adriaensen H, Hennequet-Antier C, Lainé AL, Laclie C, Papillier P, Plisson-Petit F, Estienne A, Cognié J, di Clemente N, Dalbies-Tran R, Fabre S. Prenatal programming by testosterone of follicular theca cell functions in ovary. Cell Mol Life Sci 2020;77:1177-96. [PMID: 31327046 DOI: 10.1007/s00018-019-03230-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Xu G, Zhang A, Liu J, Wang X, Feng J, Chen Y. Effects of Electroacupuncture on Ovarian Expression of the Androgen Receptor and Connexin 43 in Rats with Letrozole-Induced Polycystic Ovaries. Evid Based Complement Alternat Med 2020;2020:3608062. [PMID: 32733580 DOI: 10.1155/2020/3608062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Picton HM, Balen AH. Transgenerational PCOS transmission. Nat Med 2019;25:1818-20. [PMID: 31792458 DOI: 10.1038/s41591-019-0678-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Esparza LA, Schafer D, Ho BS, Thackray VG, Kauffman AS. Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model. Endocrinology 2020;161:bqaa018. [PMID: 32031594 DOI: 10.1210/endocr/bqaa018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Ortega MT, Carlson L, McGrath JA, Kangarloo T, Adams JM, Sluss PM, Lambert-Messerlian G, Shaw ND. AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women. J Clin Endocrinol Metab 2020;105:dgaa059. [PMID: 32016427 DOI: 10.1210/clinem/dgaa059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Witchel SF, Oberfield SE, Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc 2019;3:1545-73. [PMID: 31384717 DOI: 10.1210/js.2019-00078] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 17.3] [Reference Citation Analysis]
8 Romero-Ruiz A, Skorupskaite K, Gaytan F, Torres E, Perdices-Lopez C, Mannaerts BM, Qi S, Leon S, Manfredi-Lozano M, Lopez-Rodriguez C, Avendaño MS, Sanchez-Garrido MA, Vazquez MJ, Pinilla L, van Duin M, Kohout TA, Anderson RA, Tena-Sempere M. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome. Hum Reprod 2019;34:2495-512. [PMID: 31820802 DOI: 10.1093/humrep/dez205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Hart KN, Pépin D, Czepnik M, Donahoe PK, Thompson TB. Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2. Endocrinology 2020;161:bqaa066. [PMID: 32333774 DOI: 10.1210/endocr/bqaa066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Valdimarsdottir R, Wikström AK, Kallak TK, Elenis E, Axelsson O, Preissl H, Ubhayasekera SJKA, Bergquist J, Poromaa IS. Pregnancy outcome in women with polycystic ovary syndrome in relation to second-trimester testosterone levels. Reprod Biomed Online 2021;42:217-25. [PMID: 33077357 DOI: 10.1016/j.rbmo.2020.09.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Dalibalta S, Abukhaled Y, Samara F. Factors influencing the prevalence of polycystic ovary syndrome (PCOS) in the United Arab Emirates. Rev Environ Health 2022. [PMID: 35538690 DOI: 10.1515/reveh-2021-0036] [Reference Citation Analysis]
12 Dumesic DA, Padmanabhan V, Chazenbalk GD, Abbott DH. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation. Reprod Biol Endocrinol 2022;20:12. [PMID: 35012577 DOI: 10.1186/s12958-021-00878-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Bourgneuf C, Bailbé D, Lamazière A, Dupont C, Moldes M, Farabos D, Roblot N, Gauthier C, Mathieu d'Argent E, Cohen-Tannoudji J, Monniaux D, Fève B, Movassat J, di Clemente N, Racine C. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun 2021;12:1064. [PMID: 33594056 DOI: 10.1038/s41467-021-21308-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Du M, Zhang J, Yu X, Guan Y. Elevated Anti-Müllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:788000. [PMID: 34956097 DOI: 10.3389/fendo.2021.788000] [Reference Citation Analysis]
15 Hu M, Zhang Y, Guo X, Jia W, Liu G, Zhang J, Li J, Cui P, Sferruzzi-perri AN, Han Y, Wu X, Ma H, Brännström M, Shao LR, Billig H. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production. American Journal of Physiology-Endocrinology and Metabolism 2019;316:E794-809. [DOI: 10.1152/ajpendo.00359.2018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
16 Wawrzkiewicz-Jałowiecka A, Kowalczyk K, Trybek P, Jarosz T, Radosz P, Setlak M, Madej P. In Search of New Therapeutics-Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond. Int J Mol Sci 2020;21:E7054. [PMID: 32992734 DOI: 10.3390/ijms21197054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Li H, Guo Y, Zhang G, Deng J, Fischer H, Craig LB, Yu X, Kem DC. Gonadotrophin-releasing hormone receptor autoantibodies induce polycystic ovary syndrome-like features in a rat model. Exp Physiol 2021;106:902-12. [PMID: 33576068 DOI: 10.1113/EP089109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dumesic DA, Hoyos LR, Chazenbalk GD, Naik R, Padmanabhan V, Abbott DH. Mechanisms of intergenerational transmission of polycystic ovary syndrome. Reproduction 2020;159:R1-R13. [PMID: 31376813 DOI: 10.1530/REP-19-0197] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
19 Stepto NK, Moreno-Asso A, McIlvenna LC, Walters KA, Rodgers RJ. Molecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle? J Clin Endocrinol Metab 2019;104:5372-81. [PMID: 30938770 DOI: 10.1210/jc.2019-00167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
20 Hoyos LR, Visser JA, McLuskey A, Chazenbalk GD, Grogan TR, Dumesic DA. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS). Hum Reprod 2020;35:2294-302. [PMID: 32918081 DOI: 10.1093/humrep/deaa199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Vitale SG, Riemma G, Cianci A. Antimüllerian hormone in polycystic ovarian syndrome: from a key role in the pathogenesis to a sentinel for pre-term birth prediction. Fertil Steril 2020;113:335-6. [PMID: 32106983 DOI: 10.1016/j.fertnstert.2019.10.036] [Reference Citation Analysis]
22 Coyle C, Campbell RE. Pathological pulses in PCOS. Mol Cell Endocrinol 2019;498:110561. [PMID: 31461666 DOI: 10.1016/j.mce.2019.110561] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
23 Torchen LC, Legro RS, Dunaif A. Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2019;104:3355-61. [PMID: 30844044 DOI: 10.1210/jc.2018-02313] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
24 Wang K, Xu F, Maylie J, Xu J. Anti-Müllerian Hormone Regulation of Synaptic Transmission in the Hippocampus Requires MAPK Signaling and Kv4.2 Potassium Channel Activity. Front Neurosci 2021;15:772251. [PMID: 34975379 DOI: 10.3389/fnins.2021.772251] [Reference Citation Analysis]
25 Bar-Sadeh B, Amichai OE, Pnueli L, Begum K, Leeman G, Emes RD, Stöger R, Bentley GR, Melamed P. Epigenetic regulation of 5α reductase-1 underlies adaptive plasticity of reproductive function and pubertal timing. BMC Biol 2022;20:11. [PMID: 34996447 DOI: 10.1186/s12915-021-01219-6] [Reference Citation Analysis]
26 Burt Solorzano CM, McCartney CR. Polycystic Ovary Syndrome: Ontogeny in Adolescence. Endocrinol Metab Clin North Am 2021;50:25-42. [PMID: 33518184 DOI: 10.1016/j.ecl.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Piltonen TT, Giacobini P, Edvinsson Å, Hustad S, Lager S, Morin-Papunen L, Tapanainen JS, Sundström-Poromaa I, Arffman RK. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term. Fertil Steril 2019;111:588-596.e1. [PMID: 30630591 DOI: 10.1016/j.fertnstert.2018.11.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
28 Liao B, Qiao J, Pang Y. Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology. Front Endocrinol (Lausanne) 2021;12:667422. [PMID: 34122341 DOI: 10.3389/fendo.2021.667422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Teede H, Misso M, Tassone EC, Dewailly D, Ng EH, Azziz R, Norman RJ, Andersen M, Franks S, Hoeger K, Hutchison S, Oberfield S, Shah D, Hohmann F, Ottey S, Dabadghao P, Laven JSE. Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines. Trends Endocrinol Metab 2019;30:467-78. [PMID: 31160167 DOI: 10.1016/j.tem.2019.04.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
30 Pugeat M, Dewailly D. Epigenetics suggests new perspectives for the treatment of polycystic ovary syndrome: Transgenerational effect of fetal exposure to Antimüllerian Hormone. Ann Endocrinol (Paris) 2021;82:71-3. [PMID: 33839124 DOI: 10.1016/j.ando.2021.04.001] [Reference Citation Analysis]
31 Moore AM, Abbott G, Mair J, Prescott M, Campbell RE. Mapping GABA and glutamate inputs to gonadotrophin-releasing hormone neurones in male and female mice. J Neuroendocrinol 2018;30:e12657. [DOI: 10.1111/jne.12657] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
32 Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 19.0] [Reference Citation Analysis]
33 Min Z, Zhao Y, Hang J, Ren Y, Tan T, Fan Y, Yu Y. Neuroendocrine characteristics of induced pluripotent stem cells from polycystic ovary syndrome women. Protein Cell 2019;10:526-32. [PMID: 30535557 DOI: 10.1007/s13238-018-0600-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ho EV, Shi C, Cassin J, He MY, Nguyen RD, Ryan GE, Tonsfeldt KJ, Mellon PL. Reproductive Deficits Induced by Prenatal Antimüllerian Hormone Exposure Require Androgen Receptor in Kisspeptin Cells. Endocrinology 2021;162:bqab197. [PMID: 34529765 DOI: 10.1210/endocr/bqab197] [Reference Citation Analysis]
35 Liu JJ, Cheng Y, Shao YY, Chang ZP, Guo YT, Feng XJ, Xu D, Zhang JP, Song Y, Hou RG. Comparative pharmacokinetics and metabolites study of seven major bioactive components of Shaoyao-Gancao decoction in normal and polycystic ovary syndrome rats by ultra high pressure liquid chromatography with tandem mass spectrometry. J Sep Sci 2019;42:2534-49. [PMID: 31144455 DOI: 10.1002/jssc.201900002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
36 Hu KL, Gan K, Ying Y, Zheng J, Chen R, Xue J, Wu Y, Liu Y, Zhu Y, Xing L, Zhang D. Oligo/Amenorrhea Is an Independent Risk Factor Associated With Low Ovarian Response. Front Endocrinol (Lausanne) 2021;12:612042. [PMID: 34177795 DOI: 10.3389/fendo.2021.612042] [Reference Citation Analysis]
37 Abbott DH, Dumesic DA. Passing on PCOS: new insights into its epigenetic transmission. Cell Metab 2021;33:463-6. [PMID: 33657389 DOI: 10.1016/j.cmet.2021.02.008] [Reference Citation Analysis]
38 Witchel SF, Teede HJ, Peña AS. Curtailing PCOS. Pediatr Res 2020;87:353-61. [PMID: 31627209 DOI: 10.1038/s41390-019-0615-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
39 Franks S, Hardy K. What causes anovulation in polycystic ovary syndrome? Current Opinion in Endocrine and Metabolic Research 2020;12:59-65. [DOI: 10.1016/j.coemr.2020.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
40 Dewailly D, Barbotin AL, Dumont A, Catteau-Jonard S, Robin G. Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2020;11:641. [PMID: 33013710 DOI: 10.3389/fendo.2020.00641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
41 Mimouni NEH, Paiva I, Barbotin AL, Timzoura FE, Plassard D, Le Gras S, Ternier G, Pigny P, Catteau-Jonard S, Simon V, Prevot V, Boutillier AL, Giacobini P. Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process. Cell Metab 2021;33:513-530.e8. [PMID: 33539777 DOI: 10.1016/j.cmet.2021.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
42 Pellegrino G, Martin M, Allet C, Lhomme T, Geller S, Franssen D, Mansuy V, Manfredi-Lozano M, Coutteau-Robles A, Delli V, Rasika S, Mazur D, Loyens A, Tena-Sempere M, Siepmann J, Pralong FP, Ciofi P, Corfas G, Parent AS, Ojeda SR, Sharif A, Prevot V. GnRH neurons recruit astrocytes in infancy to facilitate network integration and sexual maturation. Nat Neurosci 2021;24:1660-72. [PMID: 34795451 DOI: 10.1038/s41593-021-00960-z] [Reference Citation Analysis]
43 Xu H, Feng G, Alpadi K, Han Y, Yang R, Chen L, Li R, Qiao J. A Model for Predicting Polycystic Ovary Syndrome Using Serum AMH, Menstrual Cycle Length, Body Mass Index and Serum Androstenedione in Chinese Reproductive Aged Population: A Retrospective Cohort Study. Front Endocrinol 2022;13:821368. [DOI: 10.3389/fendo.2022.821368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Deknuydt M, Dumont A, Bruyneel A, Dewailly D, Catteau-Jonard S. Recurrent maternal virilization during pregnancy in patients with PCOS: two clinical cases. Reprod Biol Endocrinol 2018;16:107. [PMID: 30376853 DOI: 10.1186/s12958-018-0428-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Hsu JY, James KE, Bormann CL, Donahoe PK, Pépin D, Sabatini ME. Müllerian-Inhibiting Substance/Anti-Müllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 2018;103:4187-96. [DOI: 10.1210/jc.2018-01320] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
46 Yang D, Li N, Ma A, Dai F, Zheng Y, Hu X, Wang Y, Xian S, Zhang L, Yuan M, Liu S, Deng Z, Yang Y, Cheng Y. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis. Reprod Sci 2021;28:1353-61. [PMID: 33067753 DOI: 10.1007/s43032-020-00352-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Ryu Y, Kim YJ, Kim YY, Kim J, Kim SW, Kim H, Ku SY. Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice. Int J Mol Sci 2021;22:1299. [PMID: 33525535 DOI: 10.3390/ijms22031299] [Reference Citation Analysis]
48 Wang K, Xu F, Campbell SP, Hart KD, Durham T, Maylie J, Xu J. Rapid actions of anti-Müllerian hormone in regulating synaptic transmission and long-term synaptic plasticity in the hippocampus. FASEB J 2020;34:706-19. [PMID: 31914642 DOI: 10.1096/fj.201902217R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Raperport C, Homburg R. The Source of Polycystic Ovarian Syndrome. Clin Med Insights Reprod Health 2019;13:1179558119871467. [PMID: 31516315 DOI: 10.1177/1179558119871467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
50 Abbott DH, Kraynak M, Dumesic DA, Levine JE. In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome? Front Horm Res 2019;53:1-17. [PMID: 31499494 DOI: 10.1159/000494899] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
51 McIlvenna LC, Altıntaş A, Patten RK, McAinch AJ, Rodgers RJ, Stepto NK, Barrès R, Moreno-Asso A. Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome. J Physiol 2022. [PMID: 35760527 DOI: 10.1113/JP282954] [Reference Citation Analysis]
52 Fraser GL, Obermayer-Pietsch B, Laven J, Griesinger G, Pintiaux A, Timmerman D, Fauser BCJM, Lademacher C, Combalbert J, Hoveyda HR, Ramael S. Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2021:dgab320. [PMID: 34000049 DOI: 10.1210/clinem/dgab320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Dulka EA, DeFazio RA, Moenter SM. Chemogenetic Suppression of GnRH Neurons during Pubertal Development Can Alter Adult GnRH Neuron Firing Rate and Reproductive Parameters in Female Mice. eNeuro 2020;7:ENEURO. [PMID: 32513661 DOI: 10.1523/ENEURO.0223-20.2020] [Reference Citation Analysis]
54 Liu XY, Yang YJ, Tang CL, Wang K, Chen J, Teng XM, Ruan YC, Yang JZ. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin. Fertility and Sterility 2019;111:157-67. [DOI: 10.1016/j.fertnstert.2018.09.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
55 Shah A, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Gnatuk CL, Estes SJ, Allison KC, Sarwer DB, Sluss PM, Coutifaris C, Dokras A, Legro RS. Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS. J Clin Endocrinol Metab 2021;106:108-19. [PMID: 32968804 DOI: 10.1210/clinem/dgaa682] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Aslan K, Albayrak O, Orhaner A, Kasapoglu I, Uncu G. Incidence Of Congenital Uterine Abnormalities In Polycystic Ovarian Syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 2022. [DOI: 10.1016/j.ejogrb.2022.02.012] [Reference Citation Analysis]
57 Shen H, Xu X, Fu Z, Xu C, Wang Y. The interactions of CAP and LYN with the insulin signaling transducer CBL play an important role in polycystic ovary syndrome. Metabolism 2022;:155164. [PMID: 35217034 DOI: 10.1016/j.metabol.2022.155164] [Reference Citation Analysis]
58 Stener-Victorin E, Deng Q. Transmission of Polycystic Ovary Syndrome via Epigenetic Inheritance. Trends Mol Med 2021;27:723-4. [PMID: 34127396 DOI: 10.1016/j.molmed.2021.05.005] [Reference Citation Analysis]
59 Makolle S, Catteau-Jonard S, Robin G, Dewailly D. Revisiting the serum level of anti-Müllerian hormone in patients with functional hypothalamic anovulation. Hum Reprod 2021;36:1043-51. [PMID: 33580689 DOI: 10.1093/humrep/deab024] [Reference Citation Analysis]
60 Azoulay L, Bouvattier C, Christin-Maitre S. Impact of intra-uterine life on future health. Ann Endocrinol (Paris) 2021:S0003-4266(21)01105-7. [PMID: 34896342 DOI: 10.1016/j.ando.2021.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol 2021;17:521-33. [PMID: 34234312 DOI: 10.1038/s41574-021-00517-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
62 McCartney CR, Campbell RE. Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights. Curr Opin Endocr Metab Res 2020;12:78-84. [PMID: 32676541 DOI: 10.1016/j.coemr.2020.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
63 Burger LL, Wagenmaker ER, Phumsatitpong C, Olson DP, Moenter SM. Prenatal Androgenization Alters the Development of GnRH Neuron and Preoptic Area RNA Transcripts in Female Mice. Endocrinology 2020;161:bqaa166. [PMID: 33095238 DOI: 10.1210/endocr/bqaa166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Chi H, Huang N, Liang H, Li R, Liu C, Qiao J. Abnormal Elevation of Anti-Mullerian Hormone and Androgen Levels Presenting as Granulosa Cell Tumor. Front Oncol 2021;11:641166. [PMID: 33828986 DOI: 10.3389/fonc.2021.641166] [Reference Citation Analysis]
65 Ma X, Li X, Ma L, Chen Y, He S. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway. Bioengineered 2021;12:7215-23. [PMID: 34546841 DOI: 10.1080/21655979.2021.1979864] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Doretto L, Mari FC, Chaves AC. Polycystic Ovary Syndrome and Psychotic Disorder. Front Psychiatry 2020;11:543. [PMID: 32587538 DOI: 10.3389/fpsyt.2020.00543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Vázquez-martínez ER, Gómez-viais YI, García-gómez E, Reyes-mayoral C, Reyes-muñoz E, Camacho-arroyo I, Cerbón M. DNA methylation in the pathogenesis of polycystic ovary syndrome. Reproduction 2019;158:R27-40. [DOI: 10.1530/rep-18-0449] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
68 Nóbrega JE, Tonelotto Dos Santos J, Serrano-Mujica LK, Bochi G, Moresco RN, Rissi VB, Glanzner WG, Langer FW, Antoniazzi AQ, Gonçalves PBD, Premaor MO, Comim FV. Oxidative stress and biochemical markers in prenatally androgenized sheep after neonatal treatment with GnRH agonist. J Inflamm Res 2019;12:65-71. [PMID: 30881081 DOI: 10.2147/JIR.S190260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Pépin D, Sabatini ME, Donahoe PK. Müllerian inhibiting substance/anti-Müllerian hormone as a fertility preservation agent. Curr Opin Endocrinol Diabetes Obes 2018;25:399-405. [PMID: 30320617 DOI: 10.1097/MED.0000000000000442] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
70 Barbotin AL, Peigné M, Malone SA, Giacobini P. Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function. Neuroendocrinology 2019;109:218-29. [PMID: 31280262 DOI: 10.1159/000500689] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
71 Azumah R, Hummitzsch K, Hartanti MD, St John JC, Anderson RA, Rodgers RJ. Analysis of Upstream Regulators, Networks, and Pathways Associated With the Expression Patterns of Polycystic Ovary Syndrome Candidate Genes During Fetal Ovary Development. Front Genet 2021;12:762177. [PMID: 35197999 DOI: 10.3389/fgene.2021.762177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Moore AM. Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility. Clin Endocrinol (Oxf) 2022. [PMID: 35349177 DOI: 10.1111/cen.14711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Garg A, Patel B, Abbara A, Dhillo WS. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2022. [PMID: 35262967 DOI: 10.1111/cen.14704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Kaing A, Jaswa EA, Diamond MP, Legro RS, Cedars MI, Huddleston HG. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction. Fertil Steril 2021;115:438-46. [PMID: 32883514 DOI: 10.1016/j.fertnstert.2020.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
75 di Clemente N, Racine C, Pierre A, Taieb J. Anti-Müllerian hormone in female reproduction. Endocr Rev 2021:bnab012. [PMID: 33851994 DOI: 10.1210/endrev/bnab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Valdimarsdottir R, Valgeirsdottir H, Wikström A, Kallak TK, Elenis E, Axelsson O, Ubhayasekhera K, Bergquist J, Piltonen TT, Pigny P, Giacobini P, Poromaa IS. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels. Reproductive BioMedicine Online 2019;39:141-8. [DOI: 10.1016/j.rbmo.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
77 Ahmed N, Batarfi AA, Bajouh OS, Bakhashab S. Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms. Diagnostics (Basel) 2019;9:E136. [PMID: 31581541 DOI: 10.3390/diagnostics9040136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
78 Howard JA, Hart KN, Thompson TB. Molecular Mechanisms of AMH Signaling. Front Endocrinol 2022;13:927824. [DOI: 10.3389/fendo.2022.927824] [Reference Citation Analysis]
79 Guo F, Huang Y, Fernando T, Shi Y. Altered Molecular Pathways and Biomarkers of Endometrial Receptivity in Infertile Women with Polycystic Ovary Syndrome. Reprod Sci 2022. [PMID: 35006579 DOI: 10.1007/s43032-022-00845-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Dulka EA, Burger LL, Moenter SM. Ovarian Androgens Maintain High GnRH Neuron Firing Rate in Adult Prenatally-Androgenized Female Mice. Endocrinology 2020;161:bqz038. [PMID: 31875912 DOI: 10.1210/endocr/bqz038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44:233-244. [PMID: 32648001 DOI: 10.1007/s40618-020-01351-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
82 Chehin MB, Fraietta R, Lorenzon AR, Bonetti TCS, Motta ELA. The insulin signaling pathway is dysregulated in cumulus cells from obese, infertile women with polycystic ovarian syndrome with an absence of clinical insulin resistance. Ther Adv Reprod Health 2020;14:2633494120906866. [PMID: 32596667 DOI: 10.1177/2633494120906866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Current Opinion in Pediatrics 2019;31:562-9. [DOI: 10.1097/mop.0000000000000778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 5.7] [Reference Citation Analysis]
84 Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937. [PMID: 32244180 DOI: 10.1016/j.molmet.2020.01.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 18.5] [Reference Citation Analysis]
85 Zhang FF, Zhang Q, Wang YL, Wang FF, Hardiman PJ, Qu F. Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview. J Pediatr 2021;232:272-81. [PMID: 33482217 DOI: 10.1016/j.jpeds.2021.01.018] [Reference Citation Analysis]
86 Kano M, Hsu JY, Saatcioglu HD, Nagykery N, Zhang L, Morris Sabatini ME, Donahoe PK, Pépin D. Neoadjuvant Treatment With Müllerian-Inhibiting Substance Synchronizes Follicles and Enhances Superovulation Yield. J Endocr Soc 2019;3:2123-34. [PMID: 31687639 DOI: 10.1210/js.2019-00190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
87 Wang C, Wu W, Yang H, Ye Z, Zhao Y, Liu J, Mu L. Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends in Genetics 2022. [DOI: 10.1016/j.tig.2022.01.005] [Reference Citation Analysis]
88 Ryu Y, Kim SW, Kim YY, Ku SY. Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature. Int J Mol Sci 2019;20:E2720. [PMID: 31163591 DOI: 10.3390/ijms20112720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
89 Kuang H, Duan Y, Li D, Xu Y, Ai W, Li W, Wang Y, Liu S, Li M, Liu X, Shao M. The role of serum inflammatory cytokines and berberine in the insulin signaling pathway among women with polycystic ovary syndrome. PLoS One 2020;15:e0235404. [PMID: 32785222 DOI: 10.1371/journal.pone.0235404] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
90 Silva MSB, Decoster L, Trova S, Mimouni NEH, Delli V, Chachlaki K, Yu Q, Boehm U, Prevot V, Giacobini P. Female sexual behavior is disrupted in a preclinical mouse model of PCOS via an attenuated hypothalamic nitric oxide pathway. Proc Natl Acad Sci U S A 2022;119:e2203503119. [PMID: 35867816 DOI: 10.1073/pnas.2203503119] [Reference Citation Analysis]
91 Hiam D, Simar D, Laker R, Altıntaş A, Gibson-Helm M, Fletcher E, Moreno-Asso A, Trewin AJ, Barres R, Stepto NK. Epigenetic Reprogramming of Immune Cells in Women With PCOS Impact Genes Controlling Reproductive Function. J Clin Endocrinol Metab 2019;104:6155-70. [PMID: 31390009 DOI: 10.1210/jc.2019-01015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
92 Fan L, Tang N, Yao C, Wei X, Tang Y, Li J, Huang W. Association Between Fresh Embryo Transfers and Frozen–Thawed Embryo Transfers Regarding Live Birth Rates Among Women Undergoing Long Gonadotropin-Releasing Hormone Antagonist Protocols. Front Cell Dev Biol 2022;10:884677. [DOI: 10.3389/fcell.2022.884677] [Reference Citation Analysis]
93 Silva MSB, Giacobini P. New insights into anti-Müllerian hormone role in the hypothalamic-pituitary-gonadal axis and neuroendocrine development. Cell Mol Life Sci 2021;78:1-16. [PMID: 32564094 DOI: 10.1007/s00018-020-03576-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
94 Govorov I, Sitkin S, Pervunina T, Moskvin A, Baranenko D, Komlichenko E. Metabolomic Biomarkers in Gynecology: A Treasure Path or a False Path? Curr Med Chem 2020;27:3611-22. [PMID: 30608036 DOI: 10.2174/0929867326666190104124245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Hartanti MD, Rosario R, Hummitzsch K, Bastian NA, Hatzirodos N, Bonner WM, Bayne RA, Irving-Rodgers HF, Anderson RA, Rodgers RJ. Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life? PLoS One 2020;15:e0229351. [PMID: 32078641 DOI: 10.1371/journal.pone.0229351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
96 Qi X, Yun C, Sun L, Xia J, Wu Q, Wang Y, Wang L, Zhang Y, Liang X, Gonzalez FJ, Patterson AD, Liu H, Mu L, Zhou Z, Zhao Y, Li R, Liu P, Zhong C, Pang Y, Jiang C, Qiao J. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25:1225-1233. [PMID: 31332392 DOI: 10.1038/s41591-019-0509-0] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 33.0] [Reference Citation Analysis]
97 Abdelsalam WA, Harb OA, Shazly SA. Antimullerian Hormone Levels and Association with Abortion and Preterm Delivery in Patients with Polycystic Ovary Syndrome Who Conceived with Assisted Reproductive Techniques. J Obstet Gynecol India. [DOI: 10.1007/s13224-021-01506-w] [Reference Citation Analysis]
98 Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R. Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. Int J Mol Sci 2021;22:12507. [PMID: 34830389 DOI: 10.3390/ijms222212507] [Reference Citation Analysis]
99 Teede HJ, Misso ML, Boyle JA, Garad RM, McAllister V, Downes L, Gibson M, Hart RJ, Rombauts L, Moran L, Dokras A, Laven J, Piltonen T, Rodgers RJ, Thondan M, Costello MF, Norman RJ; International PCOS Network. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Med J Aust 2018;209:S3-8. [PMID: 30453865 DOI: 10.5694/mja18.00656] [Cited by in Crossref: 25] [Cited by in F6Publishing: 39] [Article Influence: 8.3] [Reference Citation Analysis]
100 Walters KA, Gilchrist RB, Ledger WL, Teede HJ, Handelsman DJ, Campbell RE. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins. Trends Endocrinol Metab 2018;29:841-52. [PMID: 30195991 DOI: 10.1016/j.tem.2018.08.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
101 Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges, and Guiding Treatment. J Clin Endocrinol Metab 2021;106:e1071-83. [PMID: 33211867 DOI: 10.1210/clinem/dgaa839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
102 Chen X, Kong L, Piltonen TT, Gissler M, Lavebratt C. Association of polycystic ovary syndrome or anovulatory infertility with offspring psychiatric and mild neurodevelopmental disorders: a Finnish population-based cohort study. Hum Reprod 2020;35:2336-47. [PMID: 32866965 DOI: 10.1093/humrep/deaa192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
103 Hu K, Liu F, Xu H, Li R, Qiao J. High antimüllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome. Fertility and Sterility 2020;113:444-452.e1. [DOI: 10.1016/j.fertnstert.2019.09.039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
104 Zhao JJ, Kang CM, Zhang P, Zheng L. Performance characteristics of the Mindray chemiluminescence anti-Müllerian hormone assay. J Clin Lab Anal 2021;35:e23734. [PMID: 33660884 DOI: 10.1002/jcla.23734] [Reference Citation Analysis]
105 Gunning MN, van Rijn BB, Bekker MN, de Wilde MA, Eijkemans MJC, Fauser BCJM. Associations of preconception Body Mass Index in women with PCOS and BMI and blood pressure of their offspring. Gynecol Endocrinol 2019;35:673-8. [PMID: 31030581 DOI: 10.1080/09513590.2018.1563885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Owens LA, Kristensen SG, Lerner A, Christopoulos G, Lavery S, Hanyaloglu AC, Hardy K, Yding Andersen C, Franks S. Gene Expression in Granulosa Cells From Small Antral Follicles From Women With or Without Polycystic Ovaries. J Clin Endocrinol Metab 2019;104:6182-92. [PMID: 31276164 DOI: 10.1210/jc.2019-00780] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
107 Charifson MA, Trumble BC. Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder. Evol Med Public Health 2019;2019:50-63. [PMID: 31367382 DOI: 10.1093/emph/eoz011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
108 Mintziori G, Nigdelis MP, Mathew H, Mousiolis A, Goulis DG, Mantzoros CS. The effect of excess body fat on female and male reproduction. Metabolism 2020;107:154193. [PMID: 32119876 DOI: 10.1016/j.metabol.2020.154193] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
109 Liu S, Mo M, Xiao S, Li L, Hu X, Hong L, Wang L, Lian R, Huang C, Zeng Y, Diao L. Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients. Front Endocrinol (Lausanne) 2020;11:575337. [PMID: 33101210 DOI: 10.3389/fendo.2020.575337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, Engstrand L, Brusselaers N. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol 2022;20. [DOI: 10.1186/s12958-022-00905-6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
111 Sundström Poromaa I. Antimüllerian hormone and spontaneous preterm birth: more research is needed before we can change clinical guidelines. Fertil Steril 2021;115:325. [PMID: 33579523 DOI: 10.1016/j.fertnstert.2020.12.020] [Reference Citation Analysis]
112 Veikkolainen V, Ali N, Doroszko M, Kiviniemi A, Miinalainen I, Ohlsson C, Poutanen M, Rahman N, Elenius K, Vainio SJ, Naillat F. Erbb4 regulates the oocyte microenvironment during folliculogenesis. Hum Mol Genet 2020;29:2813-30. [PMID: 32716031 DOI: 10.1093/hmg/ddaa161] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Carvalho LML, dos Reis FM, Candido AL, Nunes FFC, Ferreira CN, Gomes KB. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review. Endocrine Regulations 2018;52:208-21. [DOI: 10.2478/enr-2018-0026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
114 Moore AM, Lohr DB, Coolen LM, Lehman MN. Prenatal Androgen Exposure Alters KNDy Neurons and Their Afferent Network in a Model of Polycystic Ovarian Syndrome. Endocrinology 2021;162:bqab158. [PMID: 34346492 DOI: 10.1210/endocr/bqab158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
115 Abruzzese GA, Silva AF, Velazquez ME, Ferrer MJ, Motta AB. Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development. WIREs Mech Dis 2022;:e1558. [PMID: 35475329 DOI: 10.1002/wsbm.1558] [Reference Citation Analysis]
116 Robin G, Deknuydt M, Barbotin AL, Pigny P, Catteau-Jonard S, Dewailly D. Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance. Reprod Biomed Online 2021;42:1023-31. [PMID: 33632656 DOI: 10.1016/j.rbmo.2021.01.012] [Reference Citation Analysis]
117 Abbara A, Eng PC, Phylactou M, Clarke SA, Hunjan T, Roberts R, Vimalesvaran S, Christopoulos G, Islam R, Purugganan K, Comninos AN, Trew GH, Salim R, Hramyka A, Owens L, Kelsey T, Dhillo WS. Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome. Front Endocrinol (Lausanne) 2019;10:656. [PMID: 31616381 DOI: 10.3389/fendo.2019.00656] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
118 Goldrat O, Delbaere A. PCOS: update and diagnostic approach. Clin Biochem 2018;62:24-31. [PMID: 30195483 DOI: 10.1016/j.clinbiochem.2018.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
119 Bruni V, Capozzi A, Lello S. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art. Reprod Sci . [DOI: 10.1007/s43032-021-00515-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
120 Xu J, Lawson MS, Mitalipov SM, Park BS, Xu F. Stage-specific modulation of antimüllerian hormone promotes primate follicular development and oocyte maturation in the matrix-free three-dimensional culture. Fertil Steril 2018;110:1162-72. [PMID: 30396561 DOI: 10.1016/j.fertnstert.2018.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
121 Homburg R. Where does polycystic ovary syndrome come from? Ann Transl Med 2018;6:370. [PMID: 30370297 DOI: 10.21037/atm.2018.07.25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Oride A, Kanasaki H, Tumurbaatar T, Tumurgan Z, Okada H, Kyo S. Effect of anti-Müllerian hormone in hypothalamic Kiss-1- and GnRH-producing cell models. Gynecol Endocrinol 2021;37:841-7. [PMID: 34236272 DOI: 10.1080/09513590.2021.1950134] [Reference Citation Analysis]
123 Li T, Zhang T, Cui T, Yang Y, Liu R, Chen Y, Yin C. Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome. J Steroid Biochem Mol Biol 2020;204:105752. [PMID: 32991990 DOI: 10.1016/j.jsbmb.2020.105752] [Reference Citation Analysis]
124 Bertho S, Neyroud AS, Brun T, Jaillard S, Bonnet F, Ravel C. Anti-Müllerian hormone: A function beyond the Müllerian structures. Morphologie 2021:S1286-0115(21)00251-4. [PMID: 34924282 DOI: 10.1016/j.morpho.2021.11.002] [Reference Citation Analysis]
125 Jamieson BB, Moore AM, Lohr DB, Thomas SX, Coolen LM, Lehman MN, Campbell RE, Piet R. Prenatal androgen treatment impairs the suprachiasmatic nucleus arginine-vasopressin to kisspeptin neuron circuit in female mice. Front Endocrinol 2022;13:951344. [DOI: 10.3389/fendo.2022.951344] [Reference Citation Analysis]
126 Li J, Cui L, Jiang X, Zhao H, Zhao S, Shi Y, Wei D, You L, Ma J, Chen ZJ. Transmission of polycystic ovary syndrome susceptibility single-nucleotide polymorphisms and their association with phenotype changes in offspring. Hum Reprod 2020;35:1711-8. [PMID: 32619219 DOI: 10.1093/humrep/deaa125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Qin L, Zhao S, Yang P, Cao Y, Zhang J, Chen ZJ, Dunaif A, Zhao H. Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome. Endocrine 2021;72:287-93. [PMID: 33169290 DOI: 10.1007/s12020-020-02538-4] [Reference Citation Analysis]
128 Stener-Victorin E, Padmanabhan V, Walters KA, Campbell RE, Benrick A, Giacobini P, Dumesic DA, Abbott DH. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome. Endocr Rev 2020;41:bnaa010. [PMID: 32310267 DOI: 10.1210/endrev/bnaa010] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 45.0] [Reference Citation Analysis]
129 Xu Y, Tang J, Guo Q, Xu Y, Yan K, Wu L, Xie K, Zhu A, Rong X, Ye D, Guo J. Traditional Chinese Medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice. J Ethnopharmacol 2021;268:113587. [PMID: 33212180 DOI: 10.1016/j.jep.2020.113587] [Reference Citation Analysis]
130 Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update 2021;27:584-618. [PMID: 33302299 DOI: 10.1093/humupd/dmaa051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
131 Tanimoto R, Sekii K, Morohaku K, Li J, Pépin D, Obata Y. Blocking estrogen-induced AMH expression is crucial for normal follicle formation. Development 2021;148:dev197459. [PMID: 33658225 DOI: 10.1242/dev.197459] [Reference Citation Analysis]
132 Norman RJ, Teede HJ. A new evidence‐based guideline for assessment and management of polycystic ovary syndrome. Medical Journal of Australia 2018;209:299-300. [DOI: 10.5694/mja18.00635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
133 Xu H, Zhang M, Zhang H, Alpadi K, Wang L, Li R, Qiao J. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update. Innovation (N Y) 2021;2:100091. [PMID: 34557745 DOI: 10.1016/j.xinn.2021.100091] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
134 Zhang Y, Zhao W, Xu H, Hu M, Guo X, Jia W, Liu G, Li J, Cui P, Lager S, Sferruzzi-Perri AN, Li W, Wu XK, Han Y, Brännström M, Shao LR, Billig H. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome. J Physiol 2019;597:3927-50. [PMID: 31206177 DOI: 10.1113/JP277879] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
135 Chen L, Zhang W, Huang R, Miao X, Li J, Yu D, Li Y, Hsu W, Qiu M, Zhang Z, Li F. The function of Wls in ovarian development. Mol Cell Endocrinol 2021;522:111142. [PMID: 33359762 DOI: 10.1016/j.mce.2020.111142] [Reference Citation Analysis]
136 Weedin EA, Burks HR, Yu X, Li HL, Aston CE, Kem DC, Craig LB. Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome. F S Rep 2020;1:299-304. [PMID: 34223260 DOI: 10.1016/j.xfre.2020.09.015] [Reference Citation Analysis]
137 Fu H, Lin Y, Deng X, Wu L. Correlation between anti-Mullerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes. Syst Biol Reprod Med 2021;67:112-20. [PMID: 33406916 DOI: 10.1080/19396368.2020.1860155] [Reference Citation Analysis]
138 Kim KW. Unravelling Polycystic Ovary Syndrome and Its Comorbidities. J Obes Metab Syndr 2021;30:209-21. [PMID: 34497157 DOI: 10.7570/jomes21043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Crisosto N, Ladrón de Guevara A, Echiburú B, Maliqueo M, Cavada G, Codner E, Paez F, Sir-Petermann T. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome. Fertil Steril 2019;111:381-8. [PMID: 30527840 DOI: 10.1016/j.fertnstert.2018.10.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
140 Yu CJ, Liu X, Zhou ZY, Chen XJ, Meng YC, Gu HC, Xu JJ, Ding GL, Liu XM, Sheng JZ, Huang HF. The casein kinase 2α promotes the occurrence polycystic ovary syndrome. Biochem Biophys Res Commun 2020:S0006-291X(20)30333-8. [PMID: 32081430 DOI: 10.1016/j.bbrc.2020.02.065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Gourbesville C, Kerlan V, Reznik Y. Le syndrome des ovaires polykystiques : quelles nouveautés en 2019 ?: Keeping up with PCOS in 2019. Ann Endocrinol (Paris) 2019;80 Suppl 1:S29-37. [PMID: 31606059 DOI: 10.1016/S0003-4266(19)30114-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Barsky M, Merkison J, Hosseinzadeh P, Yang L, Bruno-Gaston J, Dunn J, Gibbons W, Blesson CS. Fetal programming of polycystic ovary syndrome: Effects of androgen exposure on prenatal ovarian development. J Steroid Biochem Mol Biol 2021;207:105830. [PMID: 33515680 DOI: 10.1016/j.jsbmb.2021.105830] [Reference Citation Analysis]
143 Sansone A, Kliesch S, Isidori AM, Schlatt S. AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know? Andrology 2019;7:131-8. [DOI: 10.1111/andr.12597] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
144 Chang S, Dunaif A. Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When? Endocrinol Metab Clin North Am 2021;50:11-23. [PMID: 33518179 DOI: 10.1016/j.ecl.2020.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
145 Kuyucu Y, Sencar L, Tap Ö, Mete UÖ. Investigation of the effects of vitamin D treatment on the ovarian AMH receptors in a polycystic ovary syndrome experimental model: an ultrastructural and immunohistochemical study. Reproductive Biology 2020;20:25-32. [DOI: 10.1016/j.repbio.2020.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
146 Man L, Lustgarten Guahmich N, Kallinos E, Caiazza B, Khan M, Liu ZY, Patel R, Torres C, Pepin D, Yang HS, Bodine R, Zaninovic N, Schattman G, Rosenwaks Z, James D. Chronic superphysiologic AMH promotes premature luteinization of antral follicles in human ovarian xenografts. Sci Adv 2022;8:eabi7315. [PMID: 35263130 DOI: 10.1126/sciadv.abi7315] [Reference Citation Analysis]
147 Zuo M, Liao G, Zhang W, Xu D, Lu J, Tang M, Yan Y, Hong C, Wang Y. Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring. J Ovarian Res 2021;14:15. [PMID: 33455575 DOI: 10.1186/s13048-020-00755-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
148 Detti L, Christiansen ME, Francillon L, Ikuwezunma G, Diamond MP, Mari G, Tobiasz AM. Serum Anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses. Syst Biol Reprod Med 2019;65:147-54. [PMID: 30428262 DOI: 10.1080/19396368.2018.1537385] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
149 Wang T, Han S, Tian W, Zhao M, Zhang H. Effects of kisspeptin on pathogenesis and energy metabolism in polycystic ovarian syndrome (PCOS). Gynecological Endocrinology 2019;35:807-10. [DOI: 10.1080/09513590.2019.1597343] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
150 Mimouni NEH, Giacobini P. Polycystic ovary syndrome mouse model by prenatal exposure to high anti-Müllerian hormone. STAR Protoc 2021;2:100684. [PMID: 34401772 DOI: 10.1016/j.xpro.2021.100684] [Reference Citation Analysis]
151 Arslanca T, Ecemis T, Kiseli M, Arslanoglu E, Kotanoğlu MS, Caglar GS. Pregnancy outcome of freeze thaw cycles of polycystic ovary syndrome patients regarding the anti-Müllerian hormone percentile. J Obstet Gynaecol 2021;:1-6. [PMID: 34698605 DOI: 10.1080/01443615.2021.1962819] [Reference Citation Analysis]
152 Malone SA, Papadakis GE, Messina A, Mimouni NEH, Trova S, Imbernon M, Allet C, Cimino I, Acierno J, Cassatella D, Xu C, Quinton R, Szinnai G, Pigny P, Alonso-Cotchico L, Masgrau L, Maréchal JD, Prevot V, Pitteloud N, Giacobini P. Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism. Elife 2019;8:e47198. [PMID: 31291191 DOI: 10.7554/eLife.47198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
153 Mousa A, Joham A, Boyle J. Polycystic Ovary Syndrome. Semin Reprod Med 2021;39:69-70. [PMID: 34530478 DOI: 10.1055/s-0041-1735506] [Reference Citation Analysis]
154 Candelaria NR, Padmanabhan A, Stossi F, Ljungberg MC, Shelly KE, Pew BK, Solis M, Rossano AM, McAllister JM, Wu S, Richards JS. VCAM1 Is Induced in Ovarian Theca and Stromal Cells in a Mouse Model of Androgen Excess. Endocrinology 2019;160:1377-93. [PMID: 30951142 DOI: 10.1210/en.2018-00731] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
155 Steegers-Theunissen RPM, Wiegel RE, Jansen PW, Laven JSE, Sinclair KD. Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence. Int J Mol Sci 2020;21:E8211. [PMID: 33153014 DOI: 10.3390/ijms21218211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Piltonen TT, Arffman RK, Joham AE. Natural History of Polycystic Ovary Syndrome and New Advances in the Epidemiology. Semin Reprod Med 2021;39:94-101. [PMID: 34464984 DOI: 10.1055/s-0041-1735211] [Reference Citation Analysis]
157 Sati A, Prescott M, Holland S, Jasoni CL, Desroziers E, Campbell RE. Morphological evidence indicates a role for microglia in shaping the PCOS-like brain. J Neuroendocrinol 2021;33:e12999. [PMID: 34216402 DOI: 10.1111/jne.12999] [Reference Citation Analysis]
158 Coutinho EA, Kauffman AS. The Role of the Brain in the Pathogenesis and Physiology of Polycystic Ovary Syndrome (PCOS). Med Sci (Basel) 2019;7:E84. [PMID: 31382541 DOI: 10.3390/medsci7080084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
159 Copp T, Muscat DM, Hersch J, Mccaffery KJ, Doust J, Mol BW, Dokras A, Jansen J. Clinicians’ perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study. Human Reproduction 2020;35:660-8. [DOI: 10.1093/humrep/deaa005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
160 Silva MSB, Campbell RE. Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess. Compr Physiol 2022;12:3347-69. [PMID: 35578968 DOI: 10.1002/cphy.c210025] [Reference Citation Analysis]
161 Şahin B, Cura Şahin G, Tinelli A. Anti-Mullerian hormone levels in spontaneous pregnancies with hyperemesis gravidarum. J Obstet Gynaecol 2022;:1-5. [PMID: 35264073 DOI: 10.1080/01443615.2022.2036973] [Reference Citation Analysis]